NewLimit is a biotechnology company focused on extending human healthspan by unlocking regenerative potential. The organization emphasizes scientific research and development around regenerative biology to improve aging-related health and tissue regeneration. It conducts its work globally, highlighting science-led approaches to improve longevity and quality of life. The brand positioning centers on advancing regenerative medicine with a mission to push the boundaries of human healthspan.
No recent news for this company.
No recent deals for this company.